This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Guo S, Bozkaya D, Ward A, O'Brien JA, Ishak K, Bennett R, Al-Sabbagh A, Meletiche DM.Treating relapsing multiple sclerosis with subcutaneous versus intramuscular interferon-beta-1a: modelling the clinical and economic implications. PharmacoEconomics 27: 39-53, No. 1, Jan 2009
Rights and permissions
About this article
Cite this article
Great gains with SC IFN-β-1a in relapsing MS. Pharmacoecon. Outcomes News 572, 7 (2009). https://doi.org/10.2165/00151234-200905720-00015
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905720-00015